Endovia Health Sciences, Inc. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. The Company’s Common Stock and tradeable warrants are publicly traded on the NYSE American under the symbol “SBEV” and “SBEV WS”. Aggregate Number of Holders of Common Stock As of June 30, 2025, there were 1,899,876 shares of Common Stock issued and outstanding. As of June 30, 2025, at our transfer agent owners totaled approximately 281 holders of record of our Common Stock. Dividends We have not declared any cash dividends on our common stock since inception and do not anticipate paying such dividends in the foreseeable future. We plan to retain any future earnings for use in our business operations. Any decisions as to future payment of cash dividends will depend on our earnings and financial position and such other factors as the Board of Directors deems relevant. Securities Authorized for Issuance under Equity Compensation Plans None. Equity Compensation Plan Information The information required by this item with respect to securities authorized for issuance under equity compensation plans is set forth in Part III, Item 12 of this Annual Report on Form 10-K, and is incorporated herein by reference. Purchases of Equity Securities by the Issuer. There were no repurchases of our common stock during the year ended December 31, 2024. Item 6. {Reserved}